Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tevogen Inc.

TVGN Clue Score40
United States Fiscal year ends December CIK 0001860871

What the insiders did Net selling

By person

12 insiders · 18 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Corbin Capital Partners, L.P. entity
10% owner
—
$24.78M (2)
−$24.78M
0
$0.00
−100.0%
Semper Paratus Sponsor LLC entity
10% owner
— (1)
$8.99M (1)
−$8.99M
4,294,444
$27.48M
—
Neal Flomenberg
See Remarks
—
$2.49M (11)
−$2.49M
76,940
$492.42K
—
Ryan H. Saadi
Chief Executive Officer
$2.00K (1)
$1.77M (1)
−$1.77M
61,903,490
$396.18M
—
Kirti Desai
Chief Financial Officer
$2.46K (1)
—
+$2.46K
992,983
$6.36M
—
Sadiq Khan
Chief Commercial Officer
—
—
—
1,169,618
$7.49M
—
Surendra K Ajjarapu
CEO and Chairman
—
—
—
1,000,000
$6.40M
—
Curtis L. Patton
Director
—
—
—
139,192
$890.83K
—
Jeffrey L. Feike
Director
—
—
—
131,435
$841.18K
—
Victor J. Sordillo
Director
—
—
—
126,539
$809.85K
—
Susan M Podlogar
Director
—
—
—
123,678
$791.54K
—
Keow Lin Goh
Director
—
—
—
123,678
$791.54K
—

No percentages here. This company's share count has moved by a factor of 47.7 over the window, from 4,164,205 to 198,689,921 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.